While the COVID-19 pandemic has helped advance respiratory diagnostics and surveillance, there are still many gaps that remain across the spectrum of healthcare.
A robust stewardship program requires a comprehensive investment in technology and staff.
How pharmacists can use shared decision-making to improve antibiotic use.
Tina Tan, MD; Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Priya Nori, MD; Jacinda Abdul-Mutakabbir, PharmD; and Kevin Michael Reiter, MD, PA, provide key takeaways from the discussion on the treatment of respiratory viral infections.
A multidisciplinary panel concludes a discussion on best practices for managing patients with HIV in various healthcare settings and overcoming social health disparities.
Biologics have become a novel treatment in recurrent C. difficile.
This pathogen is the third most frequently isolated nontuberculous mycobacteria seen in the United States. Here is a review of how it presents and treatment options.
Advice to community physicians regarding ways to enhance patient-provider relationships and navigate barriers that impact the management of HIV infections.
Shorter durations of antibiotic therapy demonstrate similar efficacy and may improve safety compared with longer courses for certain infections.
Here is a review of using this therapy in this patient population.
Shortages of health care workers and an increase in COVID-19 cases has put a severe strain on the health care system. Thus, the opportunity to reduce the hospitalizations for other conditions and expand outpatient treatment opportunities should be welcomed.
Lack of data may mean bloodstream infections caused by PVCs are an overlooked cause of morbidity in hospitalized patients.
A rare case of Pott puffy tumor occurs in an atypical patient with no risk factors, likely due to untreated sinus infection.
Over half of patients admitted with positive SARS-CoV-2 testing received antibiotics, but evidence of bacterial infection is uncovered in far fewer cases. We may already be seeing the effects of antibiotic overprescribing.
The federal government is working to provide greater access to testing and treatment.
In the latest SIDP column, two clinicians provide information on recent studies and guidelines directed at antibiotic durations in this patient population.
The data from these meta-analyses highlight the value of developing systems to promote daily toothbrushing among those who have been hospitalized and, particularly, those on mechanical ventilation.
A review of the data and circumstances that led to authorization in children ages 5 to 11 years.
Since the vancomycin guideline update, institutional leaders have been faced with the challenge of implementing and monitoring AUC-guided dosing.
"This case gives uncomfortable insight into a gap in early detection of infections in immunocompromised, high-risk patient populations. "
An analysis of NHANES data looked at HCV infection and risk of prostate cancer, and found contrary evidence from previous research.
Clinicians can make room for infrequent treatment options as patients enjoy their daily lives.
Experts share advice for physicians taking care of patients with C. difficile infection (CDI).
This crisis has united multidisciplinary groups and laid the foundation to better equip the health care workforce for future pandemics.
Treatment with glecaprevir/pibrentasvir (G/P) demonstrated a virologic response at post-treatment week 12, which was superior to the prior efficacy threshold.
Patients with a penicillin allergy can be safely delabeled using minimal resources, opening up treatment options.
Management of this condition has been associated with antibiotic misuse. In the latest Bench to Bedside column, clinicians offer insights on therapy indications and what the latest literature reports on the condition.